| |
| |
|
| Insider
Information: |
Buchi J Kevin |
| Relationship: |
Director |
| City: |
West Chester |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
174,797 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$318,640 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
174,797 |
|
|
| Total
Value |
$318,640 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -63.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cephalon Inc |
CEPH |
Chief Executive Office... |
2011-10-14 |
0 |
2011-10-14 |
0 |
Premium* |
|
|
Encysive Pharmaceuticals Inc |
ENCY |
Director |
2008-04-01 |
0 |
2007-04-02 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2015-06-23 |
23,772 |
|
0 |
Premium* |
|
|
Impax Laboratories Inc |
IPXL |
Director |
2018-05-04 |
0 |
2016-11-23 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2021-03-04 |
4,167 |
2021-03-04 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
|
Ampio Pharmaceuticals Inc |
AMPE |
Director |
2023-06-09 |
146,858 |
2023-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2013-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,272 |
|
- |
|
| CEPH |
Cephalon Inc |
EVP & CFO |
• – – |
2008-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
35 |
75,656 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. Vice President & CFO |
• – – |
2007-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
80 |
72,757 |
0 |
- |
|
| CEPH |
Cephalon Inc |
EVP & CFO |
• – – |
2008-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
105 |
75,691 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2006-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
140 |
83,708 |
|
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2005-03-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
210 |
71,580 |
|
- |
|
| CEPH |
Cephalon Inc |
Exec. Vice President & CFO |
• – – |
2007-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
280 |
94,454 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2009-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
453 |
75,203 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2013-01-29 |
4 |
B |
$10.00 |
$5,000 |
D/D |
500 |
13,772 |
2.39 |
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2004-12-13 |
4 |
D |
$48.06 |
$40,274 |
D/D |
(838) |
55,053 |
|
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2003-12-12 |
4 |
D |
$47.50 |
$42,418 |
D/D |
(893) |
54,840 |
|
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$68,652 |
D/D |
(1,241) |
73,962 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2009-12-11 |
4 |
D |
$58.94 |
$73,145 |
D/D |
(1,241) |
87,721 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2009-12-14 |
4 |
D |
$59.13 |
$73,380 |
D/D |
(1,241) |
86,480 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2009-12-21 |
4 |
D |
$59.75 |
$74,150 |
D/D |
(1,241) |
85,239 |
0 |
- |
|
| CEPH |
Cephalon Inc |
officerTitle |
• – – |
2005-12-19 |
4 |
D |
$55.83 |
$69,341 |
D/D |
(1,242) |
83,848 |
|
- |
|
| CEPH |
Cephalon Inc |
Exec. Vice President and CFO |
• – – |
2006-12-01 |
4 |
D |
$75.00 |
$93,150 |
D/D |
(1,242) |
82,466 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2010-12-02 |
4 |
D |
$65.51 |
$81,363 |
D/D |
(1,242) |
83,997 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Executive Officer |
• • – |
2010-12-02 |
4/A |
D |
$65.51 |
$81,363 |
D/D |
(1,242) |
55,313 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2004-12-17 |
4 |
D |
$48.99 |
$61,874 |
D/D |
(1,263) |
71,790 |
|
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
Director |
– • – |
2007-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,383 |
1,383 |
0 |
- |
|
| CEPH |
Cephalon Inc |
officerTitle |
• – – |
2005-12-16 |
4 |
D |
$57.35 |
$85,452 |
D/D |
(1,490) |
85,090 |
|
- |
|
| CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
• – – |
2003-12-15 |
4 |
D |
$47.53 |
$73,101 |
D/D |
(1,538) |
53,302 |
|
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$111,262 |
D/D |
(1,616) |
80,967 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$121,669 |
D/D |
(1,616) |
79,351 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
